Carle Cancer Institute Normal — Normal, Illinois

Carle Cancer Institute Normal is a clinical research site located in Normal, Illinois, United States 61761.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Carle Cancer Institute Normal has participated in 91 clinical trials with 72 currently active.

Therapeutic areas: Metastatic Esophageal Adenocarcinoma, Metastatic Esophageal Squamous Cell Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma.

Sponsors: National Cancer Institute (NCI), SWOG Cancer Research Network, Children's Oncology Group.

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Carle Cancer Institute Normal?

Carle Cancer Institute Normal has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Carle Cancer Institute Normal conducted?

Carle Cancer Institute Normal has 91 clinical trials on record, with 72 currently active. Their work covers Metastatic Esophageal Adenocarcinoma, Metastatic Esophageal Squamous Cell Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma.

Is Carle Cancer Institute Normal accredited by Crixeo Health?

Carle Cancer Institute Normal has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Carle Cancer Institute Normal?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.